Rapport Therapeutics, Inc. (RAPP)

NGM – Real Time Price. Currency in USD

37.24

-1.19 (-3.10%)

At close: May 12, 2026, 4:00 PM EDT

Summary
News
Chart
Financial
Dividends
Forecast
Ownership
Profile

Revenue

Gross Profit

Operating Income

Net Income

Income Statement
Balance Sheet
Cash Flow

Income Statement (Annual)

Financials in millions USD. Fiscal year is January – December.

Name

2025

2024

2023

2022

Total Revenue

Cost of goods sold

-1M

-839K

-112K

-15K

Gross Profit

-1M

-839K

-112K

-15K

Operating expenses (excl. COGS)

-124M

-82M

-36M

-10M

Operating Income

-125M

-83M

-36M

-10M

Non-operating income, total

14M

-285K

Pretax income

-111M

-78M

-35M

-11M

Equity in earnings

Taxes

-10K

Non-controlling/minority interest

After tax other income/expense

Net income before discontinued operations

-111M

-78M

-35M

-11M

Rapport Therapeutics, Inc. (RAPP)

Get all premium features to the best stock analysis tool

Finranks

Company

Contact us

Follow us

Rapport Therapeutics, Inc. (RAPP)

Income Statement (Annual)

Income Statement (Annual)

Search stocks

Rapport Therapeutics, Inc. (RAPP)

Get all premium features to the best stock analysis tool

Finranks

Company

Contact us

Follow us

Rapport Therapeutics, Inc. (RAPP)

Income Statement (Annual)

Income Statement (Annual)